Bio-Rad Laboratories

Bio-Rad Laboratories Competitive Intelligence & Landscape

bio-rad.com ·

Overview

Bio-Rad Laboratories Overview

Bio-Rad Laboratories (bio-rad.com) is a global leader in the development, manufacturing, and marketing of a wide array of innovative products for the life science research and clinical diagnostic markets. For over 70 years, the company has focused on advancing scientific discovery and improving healthcare by providing solutions that help transform complex questions into meaningful outcomes [https://bio-rad.com/]. Their mission is to advance science and save lives, together [https://careers.bio-rad.com/].

Founded in 1952 [https://www.bio-rad.com/en-us/about/our-history?ID=1757378124555], Bio-Rad Laboratories is headquartered in Hercules, California, USA, specifically at 1000 Alfred Nobel Drive [https://www.bio-rad.com/en-us/help-center/contact-information]. The company serves a diverse target market, including universities, research institutions, hospitals, public health and commercial laboratories, food safety and environmental quality laboratories, and biopharmaceutical companies [https://www.bio-rad.com/en-uk/corporate/about-bio-rad?ID=1003].

Bio-Rad Laboratories offers a comprehensive range of products, including consumables, reagents, and instruments designed to advance research and ensure accuracy in diagnostics [https://www.bio-rad.com/en-us/p]. Their offerings span various areas such as antibodies and electrophoresis systems, supporting efforts in novel therapeutics, medical device development, and environmental understanding [https://www.bio-rad.com/en-us/p]. The company emphasizes quality and customer service, working to empower scientists and clinicians to improve lives through science [https://www.bio-rad.com/en-us/about/about-us?ID=1756930869883].

Bio-Rad Laboratories

Bio-Rad Laboratories Weekly Intel Updates

Receive weekly intel updates about Bio-Rad Laboratories straight to your inbox.

Competitors

Bio-Rad Laboratories Competitors

Bio-Rad Laboratories (bio-rad.com) navigates a competitive landscape with several major players in the life science research and clinical diagnostics markets. Among its top direct competitors is Thermo Fisher Scientific, a formidable entity known for its broad portfolio of laboratory products and services. Thermo Fisher's extensive market share and diverse offerings often place it as a direct challenger across various product categories, including reagents, instruments, and software, making it a key benchmark for features, pricing, and overall market positioning against Bio-Rad [https://www.owler.com/company/bio-rad/competitors].

Agilent Technologies stands as another significant competitor, particularly in areas involving laboratory technologies for analysis and characterization, as well as life sciences. Agilent's focus on analytical instrumentation and diagnostics solutions directly overlaps with many of Bio-Rad's offerings. While both companies vie for market share, Agilent is often highlighted for its strong customer satisfaction and product quality, positioning it as a strong alternative in the industry [https://www.comparably.com/companies/bio-rad-laboratories/competitors].

Roche, a global healthcare company, also competes with Bio-Rad, especially in the clinical diagnostics and life science research segments. Roche’s key differentiators include its extensive diagnostics portfolio, including in-vitro diagnostics and personalized healthcare solutions. Its market positioning as a leader in medical diagnostics means it competes with Bio-Rad on a global scale, particularly in areas like PCR systems and immunoassay products [https://www.owler.com/company/bio-rad/competitors].

Beckman Coulter Diagnostics is another prominent competitor, specializing in products for biomedical testing. This company develops, manufactures, and markets a wide array of products for clinical diagnostics and life science research, directly competing with Bio-Rad's diagnostic offerings. Beckman Coulter's competitive edge often lies in its integrated systems and automation solutions for laboratories, providing a strong alternative for customers seeking comprehensive diagnostic platforms [https://craft.co/bio-rad/competitors].

Finally, Danaher Corporation represents an indirect competitor, being a diversified global science and technology innovator that includes several operating companies in the life sciences and diagnostics sectors. While Danaher itself is a larger conglomerate, its various subsidiaries compete with Bio-Rad in specific niches. Danaher's broad market presence and continuous innovation across its portfolio allow it to maintain significant market share and offer a range of solutions that may indirectly compete with Bio-Rad's specialized products [https://koalagains.com/stocks/NYSE/BIO/competition].

Product & Pricing

Bio-Rad Laboratories Product and Pricing Intelligence

Bio-Rad Laboratories (bio-rad.com) offers various products and services within the life science and clinical diagnostics markets, including an array of PCR systems and assays. For example, their PrimePCR product line includes real-time PCR primer assays and probe assays for real-time PCR and Droplet Digital PCR. Pricing for PrimePCR Droplet Digital PCR assays is based on assay type and the number of reactions, with discounts available for bulk orders of the same catalog number [https://www.bio-rad.com/en-uk/product/primepcr-pcr-primers-assays-arrays?ID=M0HROA15]. An example of specific pricing is the "Leukemia, Myeloid Tier 1 H96" predesigned 96-well panel for use with SYBR® Green, which has a list price of $404.00 [https://commerce.bio-rad.com/en-us/prime-pcr-assays/pathway/leukemia-myeloid].

Bio-Rad Laboratories provides a range of Real-Time PCR Systems, such as the CFX Opus 96 Real-Time PCR System and the CFX Opus 384 Real-Time PCR System [https://www.bio-rad.com/en-us/category/real-time-pcr-systems?ID=059db09c-88a4-44ad-99f8-78635d8d54db]. The CFX Opus 384, for instance, is a 384-well, 4-color plus FRET, network-connected real-time PCR detection system [https://www.bio-rad.com/en-us/sku/12011452-cfx-opus-384-real-time-pcr-system?ID=12011452]. For detailed pricing information on these systems, customers are generally advised to contact their local Bio-Rad representative [https://www.bio-rad.com/sites/default/files/2023-04/Bulletin_7479.pdf]. The company also offers the QX700 HT Droplet Digital PCR System, which facilitates 7-color multiplexing for up to 384 samples per run and includes associated software [https://www.bio-rad.com/en-us/product/qx700-ht-droplet-digital-pcr-system?ID=4d7ba87f-1141-00ab-a440-0ed5cd2e4451].

For new laboratories or those with new grants, Bio-Rad Laboratories offers a "Transformative New Lab & New Grant Program" designed to provide tailored packages of laboratory reagents and instrumentation. This program supports a wide range of applications including digital, real-time, and conventional PCR, western blotting, cell biology, and protein purification, offering customized solutions to fit specific needs [https://www.bio-rad.com/en-us/services/new-labs-new-grants].

Customers can benefit from several free and paid features through a My Bio-Rad account. Free features include online ordering, batch number requests, standing orders, shipment tracking, and downloadable invoices. A key paid or account-specific feature is account-specific pricing, which suggests that pricing may vary based on customer agreements or volume [https://www.bio-rad.com/en-us/feature/my-bio-rad-account-advantages.html].

Ad Campaigns

Bio-Rad Laboratories Ad Campaigns

See the live ads Bio-Rad Laboratories is running across Google, Meta, and LinkedIn — the creative, messaging, and platforms behind every campaign, updated automatically by ForesightIQ.

See of Bio-Rad Laboratories's ads

View ads

Hiring & Layoffs

Bio-Rad Laboratories Hiring and Layoffs

While specific details regarding layoffs at Bio-Rad Laboratories (bio-rad.com) are not explicitly available in the provided sources, the company actively showcases a strong hiring initiative. Their careers portal careers.bio-rad.com prominently features a "We're Hiring!" message and emphasizes a mission to "advance science and save lives, together" careers.bio-rad.com. This suggests a focus on growth and expansion, aligning with their role as a global leader in developing innovative products for life science research and clinical diagnostics markets careers.bio-rad.com.

Bio-Rad Laboratories (bio-rad.com) currently lists numerous job openings across various departments and locations. Notable job openings include Quality Control Technician II, Sr. Director of Innovation and Project Management, and Software Developer IV careers.bio-rad.com/jobs/search. Other positions like Field Application Scientist and Sr. Manager, R&D Portfolio Finance and Analytics, further highlight the breadth of their hiring needs careers.bio-rad.com/jobs/field-application-scientist-california-united-states [careers.bio-rad.com/jobs/sr-manager-r-d-portfolio-finance-and-analytics-hercules-california-united-states-0cd2e981-774a-46eb-b045-6c43f4f6f9e0]. These roles span critical areas such as Research & Development, Sales & Service, Finance, and Manufacturing/Production, indicating robust activity across their core business functions careers.bio-rad.com/global-job-categories.

The company's hiring patterns signal a strategic focus on strengthening its scientific and diagnostic capabilities, as evidenced by roles in innovation, research, and quality control. The availability of both onsite and hybrid work types, in locations such as Hercules, CA (their corporate headquarters), and Irvine, CA, suggests flexibility and a commitment to attracting talent in key operational hubs careers.bio-rad.com/hercules careers.bio-rad.com/irvine careers.bio-rad.com/jobs/software-developer-iv-ref-116-1020-7-irvine-california-united-states. This ongoing recruitment drive reinforces Bio-Rad Laboratories' (bio-rad.com) commitment to advancing science and patient care, as stated in their mission to "Powering Possibilities. Saving Lives Together" bio-rad.com.

Leadership

Bio-Rad Laboratories Management and Leadership Team

Bio-Rad Laboratories (bio-rad.com) is led by an executive team focused on driving progress in biopharma, bioprocessing, and molecular diagnostics. The company's leadership ensures innovation, operational excellence, and a commitment to advancing science and healthcare. Norman Schwartz serves as the Chairman of the Board and Chief Executive Officer, a role highlighted across their corporate communications [https://www.bio-rad.com/en-us/about/corporate-officers?ID=1757380199440].

Recent leadership changes at Bio-Rad Laboratories include several key appointments. Jon DiVincenzo was named President and Chief Operating Officer, effective September 9, 2024, succeeding Andy Last [https://investors.bio-rad.com/press-releases/news-details/2024/Bio-Rad-Appoints-Jon-DiVincenzo-President-Chief-Operating-Officer/default.aspx]. Roop K. Lakkaraju joined the company as the new Executive Vice President and Chief Financial Officer [https://investors.bio-rad.com/press-releases/news-details/2024/Bio-Rad-Appoints-Roop-K.-Lakkaraju-Executive-Vice-President-Chief-Financial-Officer/default.aspx]. Additionally, Anette Engelhardt was appointed Executive Vice President and President of the Clinical Diagnostics Group, effective June 10, 2024 [https://investors.bio-rad.com/press-releases/news-details/2024/Bio-Rad-Names-Anette-Engelhardt-Executive-Vice-President-and-President-of-Clinical-Diagnostics-Group/default.aspx].

Further C-suite and leadership team appointments include Rajat Mehta as Executive Vice President, Global Commercial Operations [https://investors.bio-rad.com/press-releases/news-details/2025/Bio-Rad-Appoints-Rajat-Mehta-Executive-Vice-President-Global-Commercial-Operations/default.aspx]. The company also announced management changes within its Life Science Group, with Barry assuming the role of Executive Vice President and President of the Life Science Group [https://investors.bio-rad.com/press-releases/news-details/2024/Bio-Rad-Announces-Life-Science-Group-Management-Changes/default.aspx].

The board of directors at Bio-Rad Laboratories includes experienced professionals such as Jeffrey L. Edwards, former EVP and CFO of Allergan, Inc.; Gregory K. Hinckley, former President of Mentor Graphics Corporation; Melinda Litherland, retired Partner at Deloitte & Touche LLP; and Arnold A. Pinkston, Corporate Vice President and General Counsel of Edwards Lifesciences Corporation. Allison Schwartz also serves as Commercial Director of Bio-Rad Laboratories (Canada) Limited [https://www.bio-rad.com/webroot/web/pdf/corporate/literature/Bio-Rad-Proxy-Statement-2024.pdf].

Financials

Bio-Rad Laboratories Financial Performance, Fundraising, M&A

Bio-Rad Laboratories (bio-rad.com) demonstrates a significant presence in the life science research and clinical diagnostics markets, as reflected in its financial performance. The company reported full-year 2023 revenue of $2,671 million Bio-Rad Annual Report 2023. For the full year ended December 31, 2024, Bio-Rad recorded revenues of $2,566.5 million, with a fourth-quarter revenue of $667.5 million Bio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial Results. Looking at more recent periods, the company also released financial results for the first quarter of 2026 Bio-Rad Reports First-Quarter 2026 Financial Results and the second quarter of 2025 Bio-Rad Reports Second-Quarter 2025 Financial Results, indicating ongoing financial reporting and activity. Norman Schwartz serves as the company's Chairman and Chief Executive Officer Bio-Rad Reports First-Quarter 2026 Financial Results.

Partnerships

Bio-Rad Laboratories Partnerships, Clients and Vendors

Bio-Rad Laboratories (bio-rad.com) actively cultivates a robust network of partnerships to advance its life science research and clinical diagnostics offerings. The company has a significant collaboration with Gencurix, extending their strategic agreement for Droplet Digital™ PCR IVD oncology kits in Europe [1]. In the realm of RNA sequencing, Bio-Rad has partnered with Element Biosciences to provide a seamless workflow between Element’s AVITI™ System and Bio-Rad's SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits [2].

Bio-Rad Laboratories also engages in crucial alliances within the clinical diagnostics sector. They have expanded their joint marketing agreement with Siemens Healthineers, supplying quality control products and Unity Quality Control data management solutions [3]. Furthermore, Bio-Rad has broadened its partnership with a major diagnostics company to deliver InteliQ portfolio quality controls [5] and has specifically expanded its independent quality control products, including InteliQ and Liquichek compact vials, for the Abbott Alinity ci-series instruments [7]. Another significant collaboration involves Seegene, a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of molecular diagnostic testing products [10].

In terms of technology integration and strategic licensing, Bio-Rad has entered an exclusive licensing agreement with NuProbe USA for its allele enrichment technologies, which will be used in the development of multiplexed digital PCR assays [4]. They also collaborate with Allegheny Health Network (AHN) in a research collaboration aimed at generating clinical evidence for implementing Bio-Rad’s Droplet Digital™ PCR (ddPCR™) technology for tumor-informed molecular monitoring [8]. For data analysis, Bio-Rad offers exclusive availability of Biogazelle's qbasePLUSqPCR data analysis software for their CFX96 and CFX384 real-time PCR detection systems [9]. Additionally, Bio-Rad has partnered with ADInstruments and Vernier Software to integrate Bio-Rad Explorer classroom laboratory activities with Lt, an online learning platform [6].

Sources

Bio-Rad Extends Partnership with Gencurix Through Strategic Agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe | Bio-Rad

Bio-Rad Extends Partnership with Gencurix Through Strategic Agreement for Droplet Digital™ PCR IVD Oncology Kits in Europe | Bio-Rad

bio-rad.com

Bio-Rad and Element Biosciences Partner to Deliver Seamless RNA Sequencing Workflow Between Element’s AVITI™ System and Bio-Rad’s SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits | Bio-Rad

Bio-Rad and Element Biosciences Partner to Deliver Seamless RNA Sequencing Workflow Between Element’s AVITI™ System and Bio-Rad’s SEQuoia™ Express and SEQuoia™ Complete Stranded RNA Library Prep Kits | Bio-Rad

bio-rad.com

Bio-Rad Expands Joint Marketing Agreement with Siemens Healthineers, Providing Quality Controls to Optimize Efficiency and Data Reliability | Bio-Rad

Bio-Rad Expands Joint Marketing Agreement with Siemens Healthineers, Providing Quality Controls to Optimize Efficiency and Data Reliability | Bio-Rad

bio-rad.com

Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications | Bio-Rad

Bio-Rad and NuProbe Enter into an Exclusive Licensing Agreement for Digital PCR Applications | Bio-Rad

bio-rad.com

Bio-Rad Expands Partnership with a Major Diagnostics Company to Provide InteliQ Portfolio Quality Controls | Bio-Rad

Bio-Rad Expands Partnership with a Major Diagnostics Company to Provide InteliQ Portfolio Quality Controls | Bio-Rad

bio-rad.com

Bio-Rad Partners with ADInstruments to Integrate Bio-Rad Explorer Classroom Laboratory Activities with Lt, the Award-Winning Online Learning Platform | Bio-Rad

Bio-Rad Partners with ADInstruments to Integrate Bio-Rad Explorer Classroom Laboratory Activities with Lt, the Award-Winning Online Learning Platform | Bio-Rad

bio-rad.com

Bio-Rad Laboratories, Inc. - Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms

Bio-Rad Laboratories, Inc. - Bio-Rad Expands Range of Quality Controls for Abbott Clinical Diagnostics Platforms

investors.bio-rad.com

Bio-Rad and Allegheny Health Network Cancer Institute Partner to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR | Bio-Rad

Bio-Rad and Allegheny Health Network Cancer Institute Partner to Advance Personalized Monitoring of Solid Tumor Cancers with Droplet Digital PCR | Bio-Rad

bio-rad.com

Bio-Rad Announces the Exclusive Availability of Biogazelle's qbase PLUS  Data Analysis Software with Bio-Rad's CFX96™ and CFX384™ Real-Time PCR Systems

Bio-Rad Announces the Exclusive Availability of Biogazelle's qbase PLUS Data Analysis Software with Bio-Rad's CFX96™ and CFX384™ Real-Time PCR Systems

bio-rad.com

Bio-Rad Laboratories, Inc. - Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products

Bio-Rad Laboratories, Inc. - Bio-Rad Announces Partnership with Seegene for Molecular Diagnostic Testing Products

investors.bio-rad.com

Events

Bio-Rad Laboratories Event Participations

Bio-Rad Laboratories (bio-rad.com) actively participates in a diverse array of events, including webinars, courses, and conferences, allowing experts to share knowledge and connect with the scientific community [bio-rad.com/en-us/nws/ee]. The company hosts various educational programs and features content on life science research, clinical diagnostics, and process separations [bio-rad.com/en-us/life-science-research/events][bio-rad.com/en-us/clinical-diagnostics/support/webinars?ID=1631574160938][bio-rad.com/en-us/process-separations/events].

Bio-Rad frequently organizes webinars covering a broad spectrum of topics. These include both upcoming and on-demand sessions, such as discussions on ddPCR technology applications for rare mutation detection and gene expression, and tumor-informed ctDNA analysis [bio-rad.com/en-us/r/web]. The company's "Life Science Webinars" section offers featured series like "Coffee Chat with Bio-Rad Application Scientists" for customer Q&A, and "Blot Talk: Monthly Live Webinar Series" [bio-rad.com/en-us/life-science-research/support/webinars?ID=KVY63C4VY]. Clinical diagnostics webinars address subjects like immunohematology, including antibody identification and warm AIHA, and infectious disease testing [bio-rad.com/en-us/clinical-diagnostics/support/webinars?ID=1631574160938].

Key annual events for Bio-Rad include ddPCR World, which is described as their premier global digital PCR event series, bringing together scientists, researchers, and industry leaders through in-person and online formats [bio-rad.com/en-us/life-science-research/support/webinars/droplet-digital-pcr-world-2026?ID=1779295136574]. In 2026, ddPCR World On Tour will feature a European leg, offering a full day of expert sessions, applied demos, and peer connections at local venues for digital PCR and qPCR scientists [info.bio-rad.com/droplet-digital-pcr-world-on-tour-emea-2026.html?WT.mc_id=260410051485]. Additionally, Bio-Rad is scheduled to participate in Future Labs 2026 [bio-rad.com/en-us/life-science-research/events/future-labs-2026?ID=Future-Labs-2026_1777407167].

For process separations, Bio-Rad lists events focusing on bioprocess chromatography. These include sessions on optimizing antibody-drug conjugate (ADC) purification strategies and participation in conferences like the Bioprocessing Summit Europe and ACS BIOT [bio-rad.com/en-us/process-separations/events]. The company also offers hands-on courses, such as an "Introduction to Preparative Chromatography," in collaboration with institutions like DTU Biotech Lifelong Learning [bio-rad.com/en-nl/nws/ee].

Frequently Asked Questions

What strategic implications arise from Bio-Rad Laboratories' extensive event participation, particularly ddPCR World?

Bio-Rad Laboratories' frequent participation in and hosting of diverse events, including ddPCR World, suggests a strong strategic focus on market education, thought leadership, and direct engagement with the scientific community. ddPCR World, described as their premier global digital PCR event, highlights their commitment to showcasing and advancing their proprietary ddPCR technology, crucial for rare mutation detection and gene expression, aiming to solidify its position as an industry standard.

What can be inferred about Bio-Rad Laboratories' current growth strategy based on its hiring activity?

Bio-Rad Laboratories' strong hiring initiative, evidenced by numerous job openings across Research & Development, Sales & Service, Finance, and Manufacturing/Production, signals a strategic focus on growth and expansion. Key roles like Sr. Director of Innovation and Project Management, and Software Developer IV indicate an emphasis on strengthening scientific capabilities and product development, while Field Application Scientist roles suggest an expansion of market reach and customer support.

What is the strategic significance of Bio-Rad Laboratories' recent leadership changes, including the appointment of Jon DiVincenzo as President and COO?

The recent executive appointments at Bio-Rad Laboratories, including Jon DiVincenzo as President and COO, Roop K. Lakkaraju as EVP and CFO, and Anette Engelhardt as EVP and President of the Clinical Diagnostics Group, indicate a strategic re-alignment or reinforcement of leadership across key operational and commercial functions. These changes suggest a focus on driving progress in specific areas like biopharma, bioprocessing, and molecular diagnostics, aiming for sustained innovation and operational excellence.

How does Bio-Rad Laboratories' reported 2024 revenue compare to 2023, and what does this suggest about its market performance?

Bio-Rad Laboratories reported full-year 2024 revenue of $2,566.5 million, a decrease from its 2023 full-year revenue of $2,671 million. This suggests a slight contraction in overall revenue year-over-year, indicating potential market headwinds or shifts in demand within its life science research and clinical diagnostics markets.

What is the competitive positioning of Bio-Rad Laboratories relative to Thermo Fisher Scientific and Agilent Technologies?

Bio-Rad Laboratories faces strong competition from Thermo Fisher Scientific, which has a broad portfolio and extensive market share, and Agilent Technologies, known for analytical instrumentation and customer satisfaction. While Bio-Rad competes across similar product categories like reagents and instruments, Thermo Fisher often challenges on breadth and integrated solutions, and Agilent on product quality and analytical focus.

How does Bio-Rad Laboratories differentiate itself from alternatives like QIAGEN and Hologic?

Bio-Rad Laboratories differentiates itself from QIAGEN by offering a broader portfolio beyond QIAGEN's 'Sample to Insight' focus on molecular insights and sample preparation. Against Hologic, Bio-Rad maintains a more generalized life science and clinical diagnostics approach, while Hologic specializes in women's health diagnostics and related surgical/medical aesthetic products.

What is the strategic rationale behind Bio-Rad Laboratories' expanded partnership with Siemens Healthineers for quality control products?

Bio-Rad Laboratories' expanded joint marketing agreement with Siemens Healthineers for quality control products and Unity Quality Control data management solutions indicates a strategy to strengthen its position in clinical diagnostics. This partnership leverages Siemens Healthineers' market reach to integrate Bio-Rad's quality control solutions more broadly, potentially increasing market penetration and standardizing quality assurance practices across more diagnostic platforms.

What is the significance of Bio-Rad Laboratories' exclusive licensing agreement with NuProbe USA for allele enrichment technologies?

Bio-Rad Laboratories' exclusive licensing agreement with NuProbe USA for allele enrichment technologies is significant for enhancing its multiplexed digital PCR assay development. This partnership allows Bio-Rad to integrate advanced technologies that can improve the sensitivity and specificity of its ddPCR assays, particularly for applications requiring the detection of rare alleles, which aligns with their focus on innovation in molecular diagnostics.

How does Bio-Rad Laboratories' 'Transformative New Lab & New Grant Program' contribute to its market strategy?

The 'Transformative New Lab & New Grant Program' is a strategic initiative by Bio-Rad Laboratories to establish early relationships with new or expanding laboratories. By offering tailored packages of reagents and instrumentation, including for digital PCR, real-time PCR, and western blotting, the program aims to embed Bio-Rad's ecosystem into emerging research and diagnostic workflows, fostering long-term customer loyalty and market share.

What does the availability of account-specific pricing for My Bio-Rad account holders suggest about their sales strategy?

The availability of account-specific pricing for My Bio-Rad account holders indicates a flexible and personalized sales strategy, likely designed to cater to varying customer segments, purchase volumes, and long-term agreements. This approach allows Bio-Rad to optimize pricing for different institutional sizes or research needs, potentially fostering stronger customer relationships and incentivizing bulk or recurring purchases.

Powered by ForesightIQ · Competitive intelligence from digital exhaust